logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Levodopainduced Dyskinesia In Parkinsons Disease 1st Edition Susan H Fox

  • SKU: BELL-4929532
Levodopainduced Dyskinesia In Parkinsons Disease 1st Edition Susan H Fox
$ 31.00 $ 45.00 (-31%)

4.8

74 reviews

Levodopainduced Dyskinesia In Parkinsons Disease 1st Edition Susan H Fox instant download after payment.

Publisher: Springer-Verlag London
File Extension: PDF
File size: 5.72 MB
Pages: 368
Author: Susan H. Fox, Jonathan M. Brotchie (eds.)
ISBN: 9781447165026, 9781447165033, 1447165020, 1447165039
Language: English
Year: 2014
Edition: 1

Product desciption

Levodopainduced Dyskinesia In Parkinsons Disease 1st Edition Susan H Fox by Susan H. Fox, Jonathan M. Brotchie (eds.) 9781447165026, 9781447165033, 1447165020, 1447165039 instant download after payment.

This book aims to provide a single reference source on levodopa-induced dyskinesias (LID) from ‘bench to bedside’.

Initial chapters review the clinical features and phenomenology of LID with video examples; epidemiology and genetic risk factors for LID are covered as a background to understanding risk factors for developing LID. The following chapters cover the latest preclinical studies aiming to understand the pathophysiology of LID at the cellular, neurochemical, neurophysiological and circuitry level with detailed discussion of mechanisms and future directions to take the field forward; clinical studies from phase II to phase IV; on going RCTs in LID and evidence-based medicine reviews of treatment options.

Levodopa-Induced Dyskinesia in Parkinson’s Disease is aimed at an international audience of movement disorder neurologists; neuroscientists; trainees and graduate and post-graduate students.

Related Products